Last $0.0002 USD
Change Today 0.00 / 0.00%
Volume 0.0
NPCUF On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/10/14 All times are local (Market data is delayed by at least 15 minutes).

allon therapeutics inc (NPCUF) Snapshot

Open
$0.0002
Previous Close
$0.0002
Day High
$0.0002
Day Low
$0.0002
52 Week High
04/29/13 - $0.01
52 Week Low
04/25/13 - $0.0001
Market Cap
--
Average Volume 10 Days
1.3K
EPS TTM
$-0.06
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALLON THERAPEUTICS INC (NPCUF)

Related News

No related news articles were found.

allon therapeutics inc (NPCUF) Related Businessweek News

No Related Businessweek News Found

allon therapeutics inc (NPCUF) Details

Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. The company was formerly known as Neuro Discovery Inc. and changed its name to Allon Therapeutics Inc. in September 2004. Allon Therapeutics Inc. is headquartered in Vancouver, Canada.

8 Employees
Last Reported Date: 03/27/13

allon therapeutics inc (NPCUF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

allon therapeutics inc (NPCUF) Key Developments

TSX Determines To Delist Common Shares Of Allon Therapeutics

Further to TSX Bulletin 2013-0099 dated February 5, 2013, TSX has determined to delist the common shares of Allon Therapeutics, Inc. at the close of market on June 28, 2013 for failure to meet the continued listing requirements of TSX. In addition, the common shares are suspended from trading immediately.

Allon Therapeutics, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2013

Allon Therapeutics, Inc. reported unaudited earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported a net loss of $1,071,311 or $0.01 per share compared to $2,778,704 or $0.03 per share a year ago, representing a decrease in net loss of $1,707,393.

Allon Therapeutics, Inc. Reports Earnings Results for the Year Ended December 31, 2012

Allon Therapeutics, Inc. reported earnings results for the year ended December 31, 2012. For the year, the company reported a net loss of $14,916,297 or $0.12 per share compared to a net loss of $12,774,995 or $0.15 per share for the year ended December 31, 2011, representing an increase in net loss of $2,141,302.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NPCUF:US $0.00 USD 0.00

NPCUF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NPCUF.
View Industry Companies
 

Industry Analysis

NPCUF

Industry Average

Valuation NPCUF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLON THERAPEUTICS INC, please visit www.allontherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.